Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
Marloes J.M. Gooden, Geertruida H. de Bock, Ninke Leffers, et al.
British Journal of Cancer (2011) Vol. 105, Iss. 1, pp. 93-103
Open Access | Times Cited: 1189

Showing 26-50 of 1189 citing articles:

Targeting the tumor vasculature to enhance T cell activity
Evripidis Lanitis, Melita Irving, George Coukos
Current Opinion in Immunology (2015) Vol. 33, pp. 55-63
Open Access | Times Cited: 280
Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis
Zubing Mei, Y Liu, C Liu, et al.
British Journal of Cancer (2014) Vol. 110, Iss. 6, pp. 1595-1605
Open Access | Times Cited: 277
Neutrophil-to-lymphocyte ratio and mortality in the United States general population
Minkyo Song, Barry I. Graubard, Charles S. Rabkin, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 277
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment
Sandra P. D’Angelo, Alexander N. Shoushtari, Narasimhan P. Agaram, et al.
Human Pathology (2014) Vol. 46, Iss. 3, pp. 357-365
Open Access | Times Cited: 273
Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation
Sen Guo, Chu‐Xia Deng
International Journal of Biological Sciences (2018) Vol. 14, Iss. 14, pp. 2083-2093
Open Access | Times Cited: 267
Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors
Stuart A. Grossman, Susannah G. Ellsworth, Jian L. Campian, et al.
Journal of the National Comprehensive Cancer Network (2015) Vol. 13, Iss. 10, pp. 1225-1231
Open Access | Times Cited: 264
Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer
Michael D. Iglesia, Benjamin G. Vincent, Joel S. Parker, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 14, pp. 3818-3829
Open Access | Times Cited: 263
Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer
Jin Won Kim, Kyung Han Nam, Sang-Hoon Ahn, et al.
Gastric Cancer (2014) Vol. 19, Iss. 1, pp. 42-52
Open Access | Times Cited: 238
Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma
Aly‐Khan A. Lalani, Wanling Xie, Dylan J. Martini, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 237
Artificial Intelligence in Lung Cancer Pathology Image Analysis
Shidan Wang, Donghan M. Yang, Ruichen Rong, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1673-1673
Open Access | Times Cited: 237
B7-H1 Expression in Malignant Pleural Mesothelioma is Associated with Sarcomatoid Histology and Poor Prognosis
Aaron S. Mansfield, Anja C. Roden, Tobias Peikert, et al.
Journal of Thoracic Oncology (2014) Vol. 9, Iss. 7, pp. 1036-1040
Open Access | Times Cited: 225
First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Neeta Pandit‐Taskar, Michael A. Postow, Matthew D. Hellmann, et al.
Journal of Nuclear Medicine (2019) Vol. 61, Iss. 4, pp. 512-519
Open Access | Times Cited: 211
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
Giuseppe Badalamenti, Daniele Fanale, Lorena Incorvaia, et al.
Cellular Immunology (2018) Vol. 343, pp. 103753-103753
Closed Access | Times Cited: 200
Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma
Maria Vassilakopoulou, Margaritis Avgeris, Vamsidhar Velcheti, et al.
Clinical Cancer Research (2015) Vol. 22, Iss. 3, pp. 704-713
Open Access | Times Cited: 198
Tumor-Infiltrating Lymphocytes, Crohn’s-Like Lymphoid Reaction, and Survival From Colorectal Cancer
Laura S. Rozek, Stephanie L. Schmit, Joel K. Greenson, et al.
JNCI Journal of the National Cancer Institute (2016) Vol. 108, Iss. 8
Open Access | Times Cited: 196
CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)
Panagiotis Balermpas, Franz Rödel, Claus Rödel, et al.
International Journal of Cancer (2015) Vol. 138, Iss. 1, pp. 171-181
Open Access | Times Cited: 194
Immune and Inflammatory Cells in Thyroid Cancer Microenvironment
Silvia Martina Ferrari, Poupak Fallahi, Maria Rosaria Galdiero, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4413-4413
Open Access | Times Cited: 185
Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score)
Frédéric Bigot, Eduardo Castañón, Capucine Baldini, et al.
European Journal of Cancer (2017) Vol. 84, pp. 212-218
Closed Access | Times Cited: 179
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target
Shuang G. Zhao, Jonathan Lehrer, S. Laura Chang, et al.
JNCI Journal of the National Cancer Institute (2018) Vol. 111, Iss. 3, pp. 301-310
Closed Access | Times Cited: 172
Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results
Béatris Mastelic-Gavillet, Klara Balint, Caroline Boudousquié, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 166
Engineering universal cells that evade immune detection
Robert Lanza, David W. Russell, András Nagy
Nature reviews. Immunology (2019) Vol. 19, Iss. 12, pp. 723-733
Closed Access | Times Cited: 166
Tumour-infiltrating lymphocytes: from prognosis to treatment selection
Koen Brummel, Anneke L. Eerkens, Marco de Bruyn, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 3, pp. 451-458
Open Access | Times Cited: 123
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 99
Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy
Michael S. Hwang, Jenna VanLiere Canzoniero, Samuel Rosner, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004688-e004688
Open Access | Times Cited: 84
Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis
Linghao Meng, Yujia Yang, Xu Hu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 70

Scroll to top